AI assistant
NATIONAL RESEARCH CORP — Director's Dealing 2018
May 9, 2018
33341_dirs_2018-05-09_323a6246-3c82-4465-a404-24b481b779de.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NATIONAL RESEARCH CORP (NRCI)
CIK: 0000070487
Period of Report: 2018-05-07
Reporting Person: NUNNELLY JOHN N (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-05-07 | Common Stock | M | 5938 | $13.81 | Acquired | 57832 | Direct |
| 2018-05-07 | Common Stock | M | 4864 | $14.19 | Acquired | 62696 | Direct |
| 2018-05-07 | Common Stock | F | 4402 | $34.30 | Disposed | 58294 | Direct |
| 2018-05-07 | Common Stock | S | 2300 | $33.9189 | Disposed | 55994 | Direct |
| 2018-05-07 | Common Stock | S | 4100 | $34.5958 | Disposed | 51894 | Direct |
| 2018-05-08 | Common Stock | M | 3797 | $14.19 | Acquired | 55691 | Direct |
| 2018-05-08 | Common Stock | F | 1603 | $33.60 | Disposed | 54088 | Direct |
| 2018-05-08 | Common Stock | S | 2194 | $33.4746 | Disposed | 51894 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-05-07 | Director Stock Option (Right to Buy) | $13.81 | M | 5938 | Disposed | 2022-05-11 | Common Stock (5938) | Direct |
| 2018-05-07 | Director Stock Option (Right to Buy) | $14.19 | M | 4864 | Disposed | 2026-05-11 | Common Stock (4864) | Direct |
| 2018-05-08 | Director Stock Option (Right to Buy) | $14.19 | M | 3797 | Disposed | 2026-05-11 | Common Stock (3797) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Director Stock Option (Right to Buy) | $9.73 | 2021-05-06 | Common Stock (28763) | 28763 | Direct |
| Director Stock Option (Right to Buy) | $16.89 | 2023-05-09 | Common Stock (36000) | 36000 | Direct |
| Director Stock Option (Right to Buy) | $14.95 | 2024-05-08 | Common Stock (36000) | 36000 | Direct |
| Director Stock Option (Right to Buy) | $14.21 | 2025-05-07 | Common Stock (36000) | 36000 | Direct |
| Director Stock Option (Right to Buy) | $24.35 | 2027-05-09 | Common Stock (36000) | 36000 | Direct |
Footnotes
F1: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 29, 2018.
F2: The price in Column 4 is a weighted average price. The prices actually received ranged from $33.40 to $34.25. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.
F3: The price in Column 4 is a weighted average price. The prices actually received ranged from $34.40 to $34.666. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.
F4: The price in Column 4 is a weighted average price. The prices actually received ranged from $33.20 to $33.70. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.